Factor VIII Inhibitor Bypassing Activity (nanofiltered, vapor heat-treated)
090701
Phase 3 mab completed
Quick answer
Factor VIII Inhibitor Bypassing Activity (nanofiltered, vapor heat-treated) for Hemophilia A or B With Inhibitors is a Phase 3 program (mab) at Baxalta Innovations GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Baxalta Innovations GmbH
- Indication
- Hemophilia A or B With Inhibitors
- Phase
- Phase 3
- Modality
- mab
- Status
- completed